ARL14 and non-small cell lung carcinoma: For example, JAK/STAT signaling pathway and toll like receptor signaling pathway were activated in NSCLC samples with high ARL14 expression, and these two pathways were closely implicated in the progression of NSCLC [13, 51, 53].